CryoLife Inc (CRY) 銘柄情報

This ticker is making a habit of beating EPS and revenue guidance consistently. Targeting $25 today!

Out CRY 10.77 -.08

Oops, forgot to post - In CRY on 5/18 @ 10.85

CryoLife Fourth-Quarter-Revenues Increase 5-Percent to $37.2 Million; Full Year Revenues Increase 3 Percent to $144.6 Million

Last update: 17/02/2015 6:34:06 am

CryoLife Fourth Quarter Revenues Increase 5 Percent to $37.2 Million; Full Year Revenues Increase 3 Percent to $144.6 Million

PR Newswire

ATLANTA, Feb. 17, 2015

ATLANTA, Feb. 17, 2015 /PRNewswire/ --

Financial and Recent Highlights:
-- Product revenues grew 12 percent for the quarter and 7 percent for the
full year

-- BioGlue(R) revenues grew 11 percent for the quarter and 7 percent for the
full year

-- HeRO(R) revenues grew 10 percent for the quarter and 24 percent for the
full year

-- PerClot(R) revenues grew 52 percent for the quarter and 23 percent for
the full year

-- Tissue processing revenues decreased 4 percent for the quarter and 3
percent for the full year

-- Launched ProCol(R) and PhotoFix(TM)

-- On track to begin enrollment in PerClot IDE clinical trial in the first
quarter of 2015

CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the fourth quarter and full year of 2014. Revenues for the fourth quarter of 2014 increased 5 percent to $37.2 million compared to $35.5 million for the fourth quarter of 2013. Revenues for the full year of 2014 increased 3 percent to $144.6 million compared to $140.8 million for the full year of 2013.

Pat Mackin, President and Chief Executive Officer, said, "CryoLife had a solid fourth quarter, with double-digit revenue growth for our key medical device products, partially offset by a decline in tissue processing revenues. During the quarter we launched ProCol, followed by the launch of PhotoFix in January, adding two new key products that further leverage our sales force and strong customer relationships. We also made good progress with our pipeline initiatives and remain positioned to begin enrollment in the PerClot IDE clinical trial during the first quarter of 2015. Outside of the U.S., we remain on track with our regulatory efforts to expand the indication for BioGlue in Japan later in 2015. Altogether, this puts us in a good position in the long-term to significantly expand our higher margin medical device revenues, which continue to represent a larger mix of our overall business."

Mr. Mackin continued, "In 2015 we are investing in several strategic initiatives to enhance the long-term growth and margin expansion potential of our business. This includes the PerClot IDE trial, enhanced quality and regulatory controls for our tissue processing business, and plans to transition to a direct sales organization in one of our European territories. We also have ongoing litigation regarding PerClot that we believe is important to protect our investments in the IDE trial and future market opportunities. While these initiatives will impact our revenue growth and profitability in 2015, we believe they strongly position the Company for improved performance beginning in 2016."

Net income for the fourth quarter of 2014 was $1.8 million, or $0.06 per basic and per fully diluted common share, compared to net income of $9.0 million, or $0.33 per basic and $0.31 per fully diluted common share, for the fourth quarter of 2013. Excluding certain items as shown in the schedules below, proforma non-GAAP fully diluted earnings per share was $0.04 in the fourth quarter of 2014, compared to $0.07 in the fourth quarter of 2013.

Net income for the full year of 2014 was $7.3 million, or $0.26 per basic and $0.25 per fully diluted common share, compared to net income of $16.2 million, or $0.59 per basic and $0.57 per fully diluted common share, for the full year of 2013. Excluding certain items as shown in the schedules below, proforma non-GAAP fully diluted earnings per share was $0.18 for the full year of 2014, compared to $0.33 in 2013.

Product revenues were $21.7 million for the fourth quarter of 2014, up 12 percent from $19.4 million in the fourth quarter of 2013. Product revenues were $81.9 million for the full year of 2014, up 7 percent from $76.2 million in the full year of 2013.

Surgical sealant and hemostat revenues, which consisted primarily of sales of BioGlue and PerClot, were $17.6 million for the fourth quarter of 2014 compared to $15.6 million for the fourth quarter of 2013, an increase of 13 percent. Surgical sealant and hemostat revenues were $66.4 million for the full year of 2014 compared to $61.5 million for the full year of 2013, an increase of 8 percent. The increase in surgical sealant and hemostat revenues for the fourth quarter and full year of 2014 was due to an increase in BioGlue unit shipments into both domestic and international markets, and to a lesser extent, an increase in BioGlue average sales prices and an increase in PerClot unit shipments.

HeRO Graft revenues were $1.8 million for the fourth quarter of 2014 compared to $1.7 million in the fourth quarter of 2013, an increase of 10 percent. HeRO Graft revenues were $7.1 million for the full year of 2014 compared to $5.7 million for the full year of 2013, an increase of 24 percent.

CardioGenesis cardiac laser therapy revenues were $2.2 million for the fourth quarter of 2014 compared to $2.1 million for the fourth quarter of 2013. Cardiac laser therapy revenues were $8.2 million for the full year of 2014 compared to $9.0 million for the full year of 2013. The increase in cardiac laser therapy revenues for the fourth quarter of 2014 was primarily due to an increase in handpiece shipments, partially offset by a decrease in laser console shipments, while the decrease in the full year of 2014 was primarily due to a decrease in laser console and handpiece shipments.

Preservation services revenues were $15.5 million for the fourth quarter of 2014 compared to $16.1 million for the fourth quarter of 2013, a decrease of 4 percent. Cardiac preservation service revenues for the fourth quarter of 2014 were flat compared to the fourth quarter of 2013 and included a decrease in unit shipments, offset by an increase in average service fees. Vascular preservation services revenues decreased 7 percent for the fourth quarter of 2014 compared to the fourth quarter of 2013 due to decreases in unit shipments of vascular tissues, partially offset by an increase in average service fees.

Preservation services revenues were $62.8 million for the full year of 2014 compared to $64.5 million for the full year of 2013, a decrease of 3 percent. Cardiac preservation service revenues in the full year of 2014 were flat compared to the full year of 2013 and included a decrease in unit shipments of cardiac grafts, offset by an increase in average service fees. Vascular preservation services revenues decreased 5 percent for the full year of 2014 compared to the full year of 2013 due to a decrease in unit shipments of vascular grafts, partially offset by an increase in average service fees.

Total gross margins were 61 percent in the fourth quarter of 2014 compared to 63 percent in the fourth quarter of 2013. Product gross margins were 77 percent for the fourth quarters of 2014 and 2013. Preservation services gross margins were 39 percent and 46 percent in the fourth quarters of 2014 and 2013, respectively.

Total gross margins were 63 percent and 64 percent in the full year of 2014 and 2013, respectively. Product gross margins were 79 percent and 80 percent for the full year of 2014 and 2013, respectively. Preservation services gross margins were 42 percent and 45 percent in the full year of 2014 and 2013, respectively. The decrease in preservation services gross margin was primarily related to lower processing throughput of tissues, increased compliance and personnel costs, and an increase in the cost of materials for tissues shipped during the fourth quarter and full year of 2014.

General, administrative, and marketing expenses for the fourth quarters of 2014 and 2013 were $18.6 million and $16.7 million, respectively. General, administrative, and marketing expenses for the full year of 2014 and 2013 were $73.8 million and $68.1 million, respectively. General, administrative, and marketing expenses for the fourth quarter and full year of 2014 included approximately $565,000 and $2.0 million, respectively, in pretax compensation charges related to personnel changes.

Research and development expenses were $2.1 million and $2.5 million for the fourth quarters of 2014 and 2013, respectively. Research and development expenses were $8.7 million and $8.5 million for the full year of 2014 and 2013, respectively. Research and development spending in 2014 was focused on PerClot, tissue processing, and BioGlue and BioFoam(R) .

For the full year of 2014, the Company purchased 585,000 shares of its common stock under the repurchase program that expired in October 2014 at an average price of $9.55 per share, resulting in aggregate purchases of $5.6 million.

As of December 31, 2014, the Company had $39.3 million in cash, cash equivalents, and restricted cash and securities, compared to $43.0 million at December 31, 2013. Of this $39.3 million in cash, cash equivalents, and restricted cash and securities, $5.9 million was designated as restricted cash and securities, primarily due to a financial covenant requirement under the Company's credit agreement. The Company's net cash flows provided by operations were $4.8 million for the fourth quarter of 2014 compared to $5.5 million for the fourth quarter of 2013. The Company's net cash flows provided by operations were $8.1 million for the full year of 2014 compared to $16.8 million for the full year of 2013.

(MORE TO FOLLOW) Dow Jones Newswires

February 17, 2015 06:34 ET (11:34 GMT)

8:06AM CryoLife to acquire Hemosphere for $17 mln in cash, plus potential revenue milestone-based payments of up to $4.5 mln (CRY) 4.92 : Co announced today that it has signed a definitive agreement to acquire Hemosphere, Inc., a privately-held medical device company that has developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft. The HeRO Graft is a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction. Under terms of the agreement, CryoLife will acquire Hemosphere for $17.0 mln in cash, plus potential revenue milestone-based payments of up to $4.5 mln. CryoLife intends to use cash on hand to finance the transaction, which is expected to close in May. Hemosphere's revenues were $5.3 mln and gross margins were 65.6 percent for the full year 2011. Assuming the transaction closes in May as anticipated, the Company expects revenues of between $2.5 mln and $3.5 mln for the Hemosphere product line in 2012. The Company expects to incur between $0.09 and $0.10 per share in charges in 2012 related to the acquisition of Hemosphere, which includes non-recurring transaction and integration charges of between $0.06 and $0.08 per share, with between $0.04 and $0.05 per share of those estimated transaction and integration charges to occur during the second quarter. The Company anticipates that the transaction will be slightly dilutive to earnings to break even for 2013. The above per share charges assume a 35 percent income tax rate. However, due to the non-deductibility of certain transaction expenses, the Company expects its income tax rate in the second quarter of 2012 to be higher than 35 percen

<<< $CRY Links! >>> ~ MAC's Quick DD Links without the charts.




PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/CRY


OTC Markets Company Info ~ http://www.otcmarkets.com/stock/CRY/company-info
OTC Markets Charts ~ http://www.otcmarkets.com/stock/CRY/chart
OTC Markets Quote ~ http://www.otcmarkets.com/stock/CRY/quote
OTC Markets News ~ http://www.otcmarkets.com/stock/CRY/news
OTC Markets Financials ~ http://www.otcmarkets.com/stock/CRY/financials
OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/CRY/short-sales
OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/CRY/insider-transactions
OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/CRY/research


Google Finance Summary ~ http://www.google.com/finance?q=CRY
Google Finance News ~ http://www.google.com/finance/company_news?q=CRY
Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=CRY
Google Finance Financials ~ http://www.google.com/finance?q=CRY&fstype=ii#
Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=CRY
Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=CRY&histperiod=weekly#


Y! < Company >
Y! Profile ~ http://finance.yahoo.com/q/pr?s=CRY+Profile
Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=CRY+Key+Statistics
Y! Headlines ~ http://finance.yahoo.com/q/h?s=CRY+Headlines
Y! Summary ~ http://finance.yahoo.com/q?s=CRY
Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=CRY+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=CRY+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/CRY
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/CRY
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=CRY+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=CRY+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=CRY+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=CRY+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=CRY+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=CRY+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=CRY+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=CRY+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=CRY+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=CRY+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=CRY+Cash+Flow&annual


FINVIZ ~ http://finviz.com/quote.ashx?t=CRY&ty=c&ta=0&p=d


Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=CRY
Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=CRY
Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=CRY
Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=CRY
Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=CRY
Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=CRY&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260


CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=CRY&exchange=US


Barchart Quote ~ http://barchart.com/quotes/stocks/CRY?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/CRY
Barchart Options Quotes ~ http://barchart.com/options/stocks/CRY
Barchart Technical Chart ~ http://barchart.com/charts/stocks/CRY&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/CRY&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/CRY
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=CRY
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/CRY
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/CRY
Barchart News Headlines ~ http://barchart.com/news/stocks/CRY
Barchart Profile ~ http://barchart.com/profile//CRY
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=CRY&view=key_statistics


OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CRY&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CRY&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CRY&MarketTicker=NYSE&Typ=S


Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/CRY/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/CRY/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/CRY/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/CRY/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/CRY
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/CRY/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/CRY/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/CRY/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/CRY/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/CRY/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/CRY/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=CRY&sid=1795093&framed=False


The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=CRY


Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=CRY


StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=CRY&num1=567&cobrand=&mode=stock


StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=CRY
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=CRY


AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=CRY&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8


Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=CRY.PK&WTmodLOC=C4-Officers-5


StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=CRY®ion=U


Search NASDAQ ~ http://www.nasdaq.com/symbol/CRY
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/CRY/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/CRY/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/CRY/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=CRY&selected=CRY
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=CRY&selected=CRY
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/CRY/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/CRY/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/CRY/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/CRY/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/CRY/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/CRY/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/CRY/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/CRY/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/CRY/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/CRY/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/CRY/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/CRY/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/CRY/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/CRY/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=CRY&selected=CRY
NASDAQ Financials ~ http://www.nasdaq.com/symbol/CRY/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/CRY/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/CRY/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/CRY/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/CRY/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/CRY/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/CRY/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/CRY/insider-trades/sells


The Motley Fool ~ http://caps.fool.com/Ticker/CRY.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/CRY/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/CRY/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/CRY/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/CRY/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/CRY/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/CRY/Statements.aspx?source=icasittab0000009


MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=CRY


YCharts ~ http://ycharts.com/companies/CRY
YCharts Performance ~ http://ycharts.com/companies/CRY/performance
YCharts Dashboard ~ http://ycharts.com/companies/CRY/dashboard


InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=CRY&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=CRY&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=CRY&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=CRY


Zacks Quote ~ http://www.zacks.com/stock/quote/CRY
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=CRY
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=CRY


Knobias ~ http://knobias.10kwizard.com/files.php?sym=CRY


StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=CRY


Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/CRY/HOT_TOPIC.html


Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=CRY&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=CRY®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=CRY®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=CRY®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=CRY®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=CRY®ion=USA&culture=en-us


CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=CRY


TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=CRY


OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=CRY&searcharea=e&image1.x=0&image1.y=0


Insidercow ~ http://www.insidercow.com/history/company.jsp?company=CRY&B1=Search%21


Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=CRY
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=CRY&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=UNGS&start=1&max=10&searchResults=web&tag=web&sort=null


YouTube Symbol Search ~ http://www.youtube.com/results?search_query=CRY


Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=CRY


Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=CRY


Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=CRY

Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=CRY
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=CRY

Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=CRY

Investorpoint ~ http://www.investorpoint.com/ enter "CRY" and click search.

Hotstocked ~ http://www.hotstocked.com/ enter "CRY" and click search.

Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=CRY

Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=CRY

DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=CRY

SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=CRY

OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=CRY

Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "CRY" and click search.

http://www.coordinatedlegal.com/SecretaryOfState.html

http://regsho.finra.org/regsho-Index.html

http://www.shortsqueeze.com/?symbol=CRY&submit=Short+Quote%99



DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=CRY
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=CRY
Check those searches for recent CRY mentions. If CRY is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a complete list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS



MACDlinks

~ Thursday! $CRY ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CRY ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CRY&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CRY&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CRY
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CRY#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CRY+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CRY
Finviz: http://finviz.com/quote.ashx?t=CRY
~ BusyStock: http://busystock.com/i.php?s=CRY&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CRY >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Today I recommend buying CRY and shorting WMGI against it. This spread has the potential to make you a 10-20% spread return.

Cryo$

~ Monday! $CRY ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CRY ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CRY&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CRY&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CRY
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CRY#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CRY+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CRY
Finviz: http://finviz.com/quote.ashx?t=CRY
~ BusyStock: http://busystock.com/i.php?s=CRY&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CRY >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Looking at this.

Nice 2.6% jump up .12 for the day

CRY is under radar!

rebound tomorrow. CRY

cheap buys

this will go to $8 soon

Looking to turn around now.

looking for 8.00 by xmas, great chart!!!! The 6.20 break says it all.

Major mover last week!